Picture EBD Group BioPharm America 2018 Boston September 600x60px
Organisation › Details

Protea Biosciences (Group)

Period Start 2010-06-11 existent
Period End 2017-12-01 bankruptcy filed
Products Industry sample preparation, protein (technology)
  Industry 2 laboratory equipment and instruments
Persons Person Turner, Stephen (Steve) (Protea Biosciences 201002 CEO)
  Person 2 Kilby, Greg (Protea 201404– Chief Bioanalytics Officer before Thermo Fisher + Agilent + Pfizer)
Region Region Morgantown, WV
  Country United States (USA)
  Street 955 Hartman Run Road
  City 26507 Morgantown, WV
  Tel +1-877-776-8321
  Fax +1-304-292-7101
    Address record changed: 2013-10-04
Basic data Employees n. a.
  Currency USD
  Annual sales 2,003,286 (revenue, total (2015) 2015-12-31)
  Profit -7,140,143 (2015-12-31)
Record changed: 2018-01-18


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Protea Biosciences (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Biotech Showcase 2019 San Francisco BTS January 600x60px

» top